Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Millicent Pharma
Millicent Pharma
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Femring
Estradiol
2003-03-20
2024-2037
Prostatic neoplasms
,
Breast neoplasms
,
Menorrhagia
,
Contraception
,
Primary ovarian insufficiency
,
Hot flashes
,
Hypogonadism
,
Premature menopause
,
Leiomyoma
,
Uterine hemorrhage
,
Amenorrhea
,
Endometrial hyperplasia
,
Female infertility
,
Acne vulgaris
,
Endometriosis
,
Delayed puberty
Intrarosa
Prasterone
2016-11-16
2028-2031
Adrenal insufficiency
,
Dyspareunia
,
Postmenopause
,
Sexual and gender disorders
,
Lupus vulgaris
Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use